Deep learning-based NT-proBNP prediction from the ECG for risk assessment in the community.
Journal:
Clinical chemistry and laboratory medicine
Published Date:
Nov 20, 2023
Abstract
OBJECTIVES: The biomarker N-terminal pro B-type natriuretic peptide (NT-proBNP) has predictive value for identifying individuals at risk for cardiovascular disease (CVD). However, it is not widely used for screening in the general population, potentially due to financial and operational reasons. This study aims to develop a deep-learning model as an efficient means to reliably identify individuals at risk for CVD by predicting serum levels of NT-proBNP from the ECG.